Insider Trading Activity - Tananbaum James B.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Tananbaum James B.

Goto 0, 1, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2023-07-17 Purchase	2023-07-19 2:54 pm	Theseus Pharmaceuticals Inc.	THRX	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner	700,000	$2.97	$2,079,000	1,385,825 (Indirect)	View
2023-05-08 Purchase	2023-05-10 5:49 pm	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director 10% Owner	1,780,000	$2.8	$4,984,000	10,192,354 (Indirect)	View
2023-04-05 Purchase	2023-04-06 9:08 pm	PARDES BIOSCIENCES INC.	PRDS	Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Tananbaum James B. 10% Owner	773,952	$1.5	$1,160,928	8,773,134 (Indirect)	View
2023-04-05 Purchase	2023-04-06 9:08 pm	PARDES BIOSCIENCES INC.	PRDS	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner	773,952	$1.5	$1,160,928	13,583,762 (Indirect)	View
2022-12-29 Purchase	2023-01-03 4:24 pm	Theseus Pharmaceuticals Inc.	THRX	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner	500,000	$5	$2,500,000	1,209,275 (Indirect)	View
2022-12-01 Purchase	2022-12-05 4:24 pm	PARDES BIOSCIENCES INC.	PRDS	Foresite Capital Management V LLC Tananbaum James B. Foresite Capital Fund V L.P. 10% Owner	637,420	$0.85	$541,807	12,809,810 (Indirect)	View
2021-12-22 Purchase	2021-12-23 4:52 pm	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	325,000	$10	$3,250,000	325,000 (Indirect)	View
2021-02-19 Purchase	2021-02-23 5:34 pm	FS Development Corp. II	FSII	FS Development Holdings II LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner	602,500	$10	$6,025,000	602,500 (Direct)	View
2020-12-03 Purchase	2020-12-04 9:39 pm	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director 10% Owner	1,000,000	$20	$20,000,000	125,000 (Indirect)	View
2020-08-14 Purchase	2020-10-19 8:49 pm	FS Development Corp.	FSDC	FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner	441,500	$10	$4,415,000	441,500 (Direct)	View
2020-05-13 Sale	2020-05-14 6:01 pm	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	1,450,000	$80.13	$116,188,500	5,830,911 (Indirect)	View
2020-03-17 Sale	2020-03-19 5:15 pm	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	750,000	$59	$44,250,000	13,435,214 (Indirect)	View
2020-02-27 Sale	2020-03-02 5:01 pm	AERIE PHARMACEUTICALS INC	AERI	Foresite Capital Management II LLC Foresite Capital Fund II L.P. Foresite Capital Fund III L.P. Foresite Capital Fund IV L.P. Foresite Capital Management III LLC Foresite Capital Management IV LLC Tananbaum James B. 10% Owner	1,000,000	$17.07	$17,070,000	1,229,633 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-04-03 Disposition	2024-04-05 4:55 pm	N/A 2030-12-02	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director 10% Owner	13,779,062	$0	0 (Direct)	View
2023-08-31 Disposition	2023-08-31 5:22 pm	N/A 2033-05-31	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner	16,963,146	$0	2,000 (Direct)	View
2023-08-31 Other	2023-08-31 5:22 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner	1,000	$0	2,000 (Indirect)	View
2023-06-01 Option Award	2023-06-02 4:14 pm	N/A 2033-05-31	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Director 10% Owner	37,500	$0	37,500 (Direct)	View
2023-02-17 Other	2023-02-22 2:50 pm	N/A N/A	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director 10% Owner	1,100,000	$0	13,038,311 (Indirect)	View
2022-06-13 Option Award	2022-06-15 5:00 pm	N/A 2032-06-13	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director	20,250	$0	20,250 (Direct)	View
Ownership	2022-06-13 5:15 pm	N/A N/A	Theseus Pharmaceuticals Inc.	THRX	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner	0	$0	4,294,621 (Indirect)	View
2022-06-08 Option Award	2022-06-10 4:33 pm	N/A 2032-06-07	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Director 10% Owner	37,500	$0	37,500 (Direct)	View
2021-12-23 Option Award(A)	2022-06-10 4:17 pm	N/A 2031-12-22	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	75,000	$0	75,000 (Direct)	View
2021-12-23 Conversion(A)	2021-12-30 4:30 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	4,941,250	$0	4,941,250 (Indirect)	View
2021-12-23 Option Award	2021-12-28 4:30 pm	N/A 2031-12-22	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	7,834,072	$0	8,761,572 (Direct)	View
2021-12-23 Option Award	2021-12-28 4:30 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	1,000,000	$10	8,761,572 (Indirect)	View
2021-12-23 Conversion	2021-12-28 4:30 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	4,873,750	$0	8,761,572 (Indirect)	View
2021-11-01 Other	2021-11-03 4:17 pm	N/A N/A	Aclaris Therapeutics Inc.	ACRS	Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner	1,963,180	$0	6,628,733 (Indirect)	View
2021-10-04 Option Award	2021-10-06 4:15 pm	N/A 2021-10-03	Gemini Therapeutics Inc.	GMTX	Tananbaum James B. Director 10% Owner	17,245	$0	4,857,495 (Direct)	View
2021-06-10 Option Award	2021-06-14 6:55 pm	N/A N/A	Quantum-Si Inc	QSI	Tananbaum James B. Director	5,228,067	$0	1,618,637 (Indirect)	View
2021-06-10 Option Award	2021-06-14 6:55 pm	N/A N/A	Quantum-Si Inc	QSI	Tananbaum James B. Director	348,125	$0.001	1,618,637 (Indirect)	View
2021-06-10 Option Award	2021-06-14 6:55 pm	N/A N/A	Quantum-Si Inc	QSI	Tananbaum James B. Director	1,250,000	$10	1,618,637 (Indirect)	View
Ownership	2021-02-16 9:41 pm	N/A N/A	FS Development Corp. II	FSII	Tananbaum James B. President and CEO 10% Owner	0	$0	5,031,250 (Indirect)	View
Ownership	2021-02-10 6:00 pm	N/A N/A	Aclaris Therapeutics Inc.	ACRS	Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner	0	$0	6,612,181 (Indirect)	View
2021-02-05 Option Award	2021-02-09 4:00 pm	N/A N/A	Gemini Therapeutics Inc.	GMTX	Tananbaum James B. Director	1,500,000	$10	3,370,250 (Indirect)	View
2021-02-05 Conversion	2021-02-09 4:00 pm	N/A N/A	Gemini Therapeutics Inc.	GMTX	Tananbaum James B. Director	2,928,750	$0	3,370,250 (Indirect)	View
2020-12-07 Conversion	2020-12-09 4:12 pm	N/A N/A	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director 10% Owner	19,675,448	$0	291,667 (Indirect)	View
2020-12-02 Option Award	2020-12-04 6:32 pm	N/A 2030-12-02	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director 10% Owner	40,501	$0	40,501 (Direct)	View
Ownership	2020-12-02 9:06 pm	N/A N/A	Kinnate Biopharma Inc.	KNTE	Tananbaum James B. Director 10% Owner	0	$0	9,838,311 (Indirect)	View
Ownership(A)	2020-08-19 9:14 pm	N/A N/A	FS Development Corp.	FSDC	Tananbaum James B. President & CEO 10% Owner	0	$0	3,018,750 (Indirect)	View
2020-05-12 Conversion	2020-05-14 6:01 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	1,930,198	$0	5,830,911 (Indirect)	View
2020-05-06 Conversion	2020-05-08 08:39 am	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	2,000,000	$0	8,411,109 (Indirect)	View
2020-04-23 Conversion	2020-04-24 5:00 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	1,000,000	$0	11,602,954 (Indirect)	View
2020-04-22 Other	2020-04-24 5:00 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	970,842	$0	11,602,954 (Indirect)	View
2020-04-14 Conversion	2020-04-15 5:00 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	1,500,000	$0	11,361,219 (Indirect)	View
2020-04-13 Other	2020-04-15 5:00 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	1,554,692	$0	11,361,219 (Indirect)	View
2020-03-24 Conversion	2020-03-26 5:53 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	2,170,619	$0	12,500,846 (Indirect)	View
2020-03-04 Conversion	2020-03-19 5:15 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	2,130,804	$0	13,435,214 (Indirect)	View
2020-03-18 Other	2020-03-19 5:15 pm	N/A N/A	10x Genomics Inc.	TXG	Foresite Capital Management I LLC Foresite Capital Fund I L.P. Foresite Capital Management II LLC Foresite Capital Fund II L.P. Tananbaum James B. 10% Owner	1,313,974	$0	13,435,214 (Indirect)	View
2019-12-20 Exercise	2019-12-23 6:05 pm	N/A 2019-12-20	AERIE PHARMACEUTICALS INC	AERI	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Tananbaum James B. 10% Owner	289	$0	5,524,591 (Indirect)	View
2019-12-20 Exercise	2019-12-23 6:05 pm	N/A N/A	AERIE PHARMACEUTICALS INC	AERI	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Tananbaum James B. 10% Owner	28,900	$30	5,524,591 (Indirect)	View

(A) Indicate amendment filing.

Goto 0, 1, Next

Insider Trading & Ownership - Tananbaum James B.